No quarterly revenue total was found in TRAFALGAR INTERNATIONAL, INC.'s SEC filings.
Trafalgar International, Inc. (TRFA) files with the SEC under industry code 2834, Pharmaceutical Preparations.
Revenue
—
Net income
$611,378
+256.4% vs year-ago quarter
Operating cash flow
$-6,828
+65.0% vs year-ago quarter
Free cash flow
—
EPS
$0.61
+241.9% vs year-ago quarter
Dividend per share
None
Shares outstanding
994,379
-99.9% vs year-ago quarter
Net cash
—
Operating margin
—
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- TRFA (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- FL
- Headquarters
- Miami, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1695473
- Former names
- Greater Cannabis Company, Inc. (until Jul 31, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Operating income | -$11,555 | -$33,376 | -$53,806 | -$37,412 | -$48,251 |
| Net income | $611,378 | -$33,376 | $337,757 | -$36,099 | -$390,853 |
| Diluted EPS | $0.61 | $0.00 | $0.36 | -$0.04 | -$0.43 |
| Operating cash flow | -$6,828 | -$4,376 | -$24,140 | -$5,357 | -$19,501 |
| Total assets | $111 | $1,439 | $815 | $21,355 | $26,712 |
| Total liabilities | $12,239 | $776,464 | $742,464 | $1.1M | $1.1M |
| Stockholders' equity | -$12,128 | -$775,025 | -$741,649 | -$1.1M | -$1.1M |
| Cash and investments | $111 | $1,439 | — | $21,355 | $26,712 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Oct 14, 2026 | Oct 12, 2026 |
| 8-K |
Current report
Officer or director change
|
Sep 21, 2026 | Sep 18, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Other events
|
Jul 31, 2026 | Jul 29, 2026 |
| 8-K |
Current report
Material agreement, Change in control, Officer or director change
|
Jul 6, 2026 | Jun 29, 2026 |
| 10-Q | Quarterly report | May 13, 2026 | Mar 31, 2026 |
All 144 Trafalgar International, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.